In this mechanism, the binding of NMO-IgG to AQP4 induces its endocytosis, which causes concomitant loss of excitatory amino acid transporter 2 (EAAT2), followed by disruption of glutamate homeostasis [25,26,27]. The gene discussed is SLC1A2; the disease is neuromyelitis optica.